| Drug Name | Active Ingredient | Dosage Form | Strength | Manufacturers | Manufacturers | Approval No. | Same Variety(Same Strength) | Approval Date | Drug Classification | Details |
|---|---|---|---|---|---|---|---|---|---|---|
| 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | 3ml:300单位（笔芯） | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | 国药准字S20227009 | view | 2022-07-26 | Medicare(class B) | view |
| 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | 3ml：300单位（笔芯） | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | 国药准字S20220031 | view | 2022-11-08 | Medicare(class B) | view |